Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market
Go back to Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market| (NASDAQ: INBS) | Delayed: 2.20 -0.03 (1.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.23 | 52 Week High | $ | |||
| Open | $2.25 | 52 Week Low | $ | |||
| Day High | $2.29 | P/E | N/A | |||
| Day Low | $2.17 | EPS | $ | |||
| Volume | 25,509 | |||||
| (NASDAQ: INBS) | Delayed: 2.20 -0.03 (1.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.23 | 52 Week High | $ | |||
| Open | $2.25 | 52 Week Low | $ | |||
| Day High | $2.29 | P/E | N/A | |||
| Day Low | $2.17 | EPS | $ | |||
| Volume | 25,509 | |||||

